Top accelerator startups

14,448 startups · 29 programs

Spect

Inactive · Value-based retinal screening in primary care to prevent blindness.

2signal of 100 · rising 0
  • team of 7Team size · YC's directory+4.7
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S17 in AI

All of S17

About Spect

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

YC batch
S17 · Summer 2017
Status, per YC
Inactive
Category
AI
Team size
7
Location
San Francisco, CA, USA; Palo Alto, CA, USA; Remote
Checked
6h ago

YC tags: Digital Health, AI

Spect in S17: 125 companies, 27% AI

Spect: questions

Which YC batch was Spect in?

Spect was in Y Combinator's Summer 2017 batch (S17).

Is Spect still active?

Y Combinator lists Spect as inactive.

Where is Spect based?

Spect lists San Francisco, CA, USA; Palo Alto, CA, USA; Remote as its location on YC's directory.